Morning Buzz: Symantec (SYMC), Ironwood Pharmaceuticals (IRWD), Microsoft (MSFT), Clean Diesel Technologies (CDTI)

Shares of Symantec Corporation (SYMC) are up slightly in pre-market trading on Wednesday, following this morning’s Bloomberg report that said Symantec is nearing a deal to sell its Veritas data-storage business to Carlyle Group LP for $7 billion to $8 billion.

Shares of Ironwood Pharmaceuticals, Inc. (IRWD) up more than 2% this morning after Ironwood Pharma and AstraZeneca announced that top-line data from a Phase III clinical trial of adults with irritable bowel syndrome with constipation (IBS-C) demonstrated linaclotide met all primary and secondary endpoints. The companies said the trial was conducted primarily in China and that they intend to file in early 2016 for China Food and Drug Administration [CFDA] approval to market linaclotide.

Microsoft Corporation (MSFT) shares are down 0.54% to $44.06 in early trading Wednesday. The New York Times reports the Redmond, Washington-based firm will announce a new round of layoffs as early as today. The plans to layoff up to 7,800 workers, which is in addition to about 18,000 employees M’soft said it was dropping about a year ago, is to cut costs amid waning demand for some of the software giant’s devices and services.

The layoffs are expected to include those working in Microsoft’s hardware group.

Shares of Clean Diesel Technologies Inc. (CDTI) are higher by nearly 6% to $1.85 in pre-market trading on Wednesday after the company announced it has received certification from the Verification of Emission Reduction Technologies Association (VERT®) for CDTi’s Purifilter® EGR diesel particulate filter (DPF) system. Clean Diesel said this recognition expands its retrofit market by enabling it to address opportunities in South America and other international locations.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.